Nicoletta C Machin
Quick facts
Marketed products
- Recombinant Von Willebrand factor · Hematology
Recombinant von Willebrand factor replaces or supplements the natural von Willebrand factor protein to restore platelet adhesion and coagulation factor VIII binding.
Phase 3 pipeline
- IV Iron (standard of care) · Hematology
IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: